(Reuters) -The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be ...

Only seven jurisdictions are still reporting high flu activity, and for COVID, wastewater detections returned to the low ...

The FDA has granted Visby Medical authorization to market their at-home, over-the-counter diagnostic test that detects ...

The Food and Drug Administration (FDA) has cleared the Visby Medical Women’s Sexual Health Test for use at home to test for ...

The FDA on Friday granted marketing authorization to the first at-home test for diagnosing chlamydia, gonorrhea, and trichomoniasis in females. The so-called Visby Medical Women's ...

The US Food and Drug Administration (FDA) today approved the first at-home, over-the-counter test for chlamydia, gonorrhea, and trichomoniasis.

The FDA has cleared its first completely at-home sexual health test for women, available over-the-counter to screen for ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

The U.S. Food and Drug Administration (FDA) has granted marketing authorization to Visby Medical for its Women’s Sexual Health Test, the first home diagnostic test for chlamydia, gonorrhea, and ...

Visby Medical™, a leading innovator in medical diagnostics, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the Visby Medical Women's Sexual Health ...

The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics ...